CD4 and neoplasm: In the current study, we demonstrate that the loss of infiltrating Tregs not only enhanced early-stage CD8+ TIL effector activity but also inhibited TOX induction, preventing the CD4+ T cell transition into functional exhaustion during tumor progression.